Correspondence 0001193125-23-301172 from Korro Bio, Inc. (KRRO) (CIK 0001703647) (KRRO)
Korro Bio, Inc. (KRRO) (CIK 0001703647)
Date: Dec. 21, 2023 · CIK: 0001703647 · Accession: 0001193125-23-301172
AI Filing Summary & Sentiment
File numbers found in text: 333-275353
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Attention: Ms. Doris Stacey Gama Requested Date: December 22, 2023 Requested Time: 4:05 p.m., Eastern Time
Dear Ms. Gama and Mr. McCann:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Korro Bio, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to December 22, 2023, at 4:05 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP, by calling Marianne Sarrazin at (415) 733-6134.
If you have any questions regarding this request, please contact Marianne Sarrazin of Goodwin Procter LLP at (415) 733-6134.
Sincerely,
KORRO BIO, INC.
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request VIA EDGAR December 21, 2023 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Ms. Doris Stacey Gama Mr. Joe McCann Re: Korro Bio, Inc. Acceleration Request for Registration Statement on Form S-1 File No. 333-275353 Acceleration Request Requested Date: December 22, 2023 Requested Time: 4:05 p.m., Eastern Time Dear Ms. Gama and Mr. McCann: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Korro Bio, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to December 22, 2023, at 4:05 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP, by calling Marianne Sarrazin at (415) 733-6134. If you have any questions regarding this request, please contact Marianne Sarrazin of Goodwin Procter LLP at (415) 733-6134. Sincerely, KORRO BIO, INC. /s/ Ram Aiyar Ram Aiyar President, Chief Executive Officer and Director Korro Bio, Inc. cc: Vineet Agarwal, Chief Financial Officer, Korro Bio, Inc. Shelby Walker, General Counsel, Korro Bio, Inc. Kingsley L. Taft, Esq., Goodwin Procter LLP Daniel Hughes, Esq., Goodwin Procter LLP